Overview
Whether you arrived from a “Injective vs Raydium” query or from PEPS coin pages, this hub aggregates ranks, performance and module-backed signals into one canonical URL.
Quick winners
Full comparison
| Metric | INJ | RAY |
|---|---|---|
| Price | $4.97 | $0.605414 |
| Market Cap | $490.41M | $163.09M |
| FDV | — | — |
| Volume 24h | $3.42M | $7.14M |
| Circulating Supply | — | — |
| Total Supply | — | — |
| Max Supply | — | — |
| Rank | 100.00 | 180.00 |
| Dominance | — | — |
| Liquidity | — | — |
| Volatility | +5.78% | +3.50% |
| ATH | — | — |
| ATL | — | — |
| ROI | — | — |
Performance
| Timeframe | INJ | RAY |
|---|---|---|
| 1H | — | — |
| 24H | +0.95% | -1.70% |
| 7D | — | — |
| 30D | — | — |
| 90D | — | — |
| 1Y | — | — |
| YTD | — | — |
| ALL | — | — |
Comparative chart
Technical indicators
| Indicator | INJ | RAY |
|---|---|---|
| RSI | 53.92 | 54.31 |
| MACD histogram | — | — |
| EMA20 | — | — |
| EMA50 | — | — |
| EMA100 | — | — |
| EMA200 | — | — |
| SMA50 | — | — |
| SMA200 | — | — |
| ATR | 0.29 | 66.45 |
| ADX | 12.69 | 20.44 |
| Support | 4.91 | 1,827.82 |
| Resistance | 5.03 | 1,960.30 |
| Trend | neutral | bearish |
| Momentum | — | 63.00 |
| Signal | neutral | neutral |
Automatic technical analysis
Indicator stacks for INJ/RAY currently lean on separate regimes: neutral versus bearish. Treat MACD and RSI as context, not as standalone entry triggers.
Fundamentals
| Metric | INJ | RAY |
|---|---|---|
| Consensus | — | — |
| Blockchain | — | — |
| TPS | — | — |
| Block time | — | — |
| Finality | — | — |
| Validators | — | — |
| Staking | — | — |
| TVL | — | — |
| Supply model | — | — |
| Inflation | — | — |
| Developer activity | 0.00 | — |
| Github activity | 118.00 | — |
| On-chain activity | — | — |
| Whale activity | — | — |
| Addresses | — | — |
| Gas fees | — | — |
Ecosystem
Injective
Raydium
Pros and cons
Pros of Injective
- Higher ranking for Injective can translate into tighter spreads on major venues.
- Injective has an established coin page footprint on PEPS for continuous monitoring.
- INJ often anchors narratives that attract sustained media and analyst coverage.
Cons of Injective
- When dominance narratives fade, Injective can lag hotter rotation names.
- Crowded positioning around INJ sometimes amplifies squeeze or flush risk.
- Regulatory or macro headlines can hit Injective harder simply because it is more visible.
Pros of Raydium
- Active volume bursts on RAY sometimes precede sharper tactical moves.
- Diversifying versus Injective with Raydium can change portfolio factor exposure.
- If technical momentum aligns, Raydium may outperform on medium-term windows.
Cons of Raydium
- Weaker market-cap standing may leave Raydium more exposed to liquidity droughts.
- Smaller book depth versus large caps can increase slippage for Raydium.
- Relative underperformance versus Injective can persist through entire market regimes.
- Trend failures on Raydium often travel faster than on more established assets.
Which looks stronger right now?
Data currently points to a probabilistic edge for Injective on size and Raydium on activity. Neither reading guarantees future returns.
AI summary
Comparing INJ and RAY begins with structure: capitalization, volume and rank. Present prints are $4.97 versus $0.605414. Momentum and trend can disagree with market-cap hierarchy. That is normal in crypto rotations and should be stress-tested against supports and news flow. Canonical URLs prevent duplicate RAY-vs-INJ pages, keeping SEO equity on one comparison. Keep monitoring winners as data updates.
FAQ
Which is better, Injective or Raydium?
“Better” depends on horizon and risk. Injective leads on market cap today, while Injective leads the 24h move — neither is a guarantee.
Which has more upside potential, INJ or RAY?
Higher-beta assets can move more in both directions. Use performance tables and volatility, not headlines, to judge potential ranges.
Which is less risky right now?
Lower volatility and deeper liquidity usually imply milder path risk, but crypto tails remain large for both Injective and Raydium.
Which has stronger developer activity?
Check the fundamentals table for developer/github fields when populated. Missing values mean the feed has no reliable reading yet.
Which looks more decentralized?
Decentralization is multi-dimensional (validators, client diversity, token distribution). This page surfaces available consensus/validator fields without over-claiming.
Which has lower fees?
Fee comparisons belong to each network’s fee market. Where gas/fee metrics exist in fundamentals, compare them; otherwise verify on explorers.
Which is better for investing?
Investing choices need personal constraints. Use this comparison as research input, then size positions with an explicit invalidation plan.
Which is better for staking?
If staking fields are present, compare yield mechanics and lockups off-platform. Staking returns are not risk-free.
Which is more used day to day?
Volume, on-chain activity and ecosystem links are practical usage proxies. Raydium currently leads traded volume on this snapshot.
Which has the better recent performance?
See the performance table across 1h through 1y. The 24h leader is Injective, but longer windows can disagree.